IRIS Accounts Production v24.2.0.383 14074050 director 1.5.23 30.4.24 30.4.24 0 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh140740502023-04-30140740502024-04-30140740502023-05-012024-04-30140740502022-04-26140740502022-04-272023-04-30140740502023-04-3014074050ns15:EnglandWales2023-05-012024-04-3014074050ns14:PoundSterling2023-05-012024-04-3014074050ns10:Director12023-05-012024-04-3014074050ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3014074050ns10:SmallEntities2023-05-012024-04-3014074050ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3014074050ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3014074050ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3014074050ns10:FullAccounts2023-05-012024-04-301407405012023-05-012024-04-3014074050ns10:RegisteredOffice2023-05-012024-04-3014074050ns5:CurrentFinancialInstruments2024-04-3014074050ns5:CurrentFinancialInstruments2023-04-3014074050ns5:ShareCapital2024-04-3014074050ns5:ShareCapital2023-04-3014074050ns5:RetainedEarningsAccumulatedLosses2024-04-3014074050ns5:RetainedEarningsAccumulatedLosses2023-04-3014074050ns5:NetGoodwill2023-05-012024-04-3014074050ns5:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3014074050ns5:PlantMachinery2023-05-012024-04-3014074050ns5:NetGoodwill2023-04-3014074050ns5:NetGoodwill2024-04-3014074050ns5:NetGoodwill2023-04-3014074050ns5:PlantMachinery2023-04-3014074050ns5:PlantMachinery2024-04-3014074050ns5:PlantMachinery2023-04-3014074050ns5:CostValuation2023-04-3014074050ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3014074050ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 14074050 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

Visanta Health Limited

Visanta Health Limited (Registered number: 14074050)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Visanta Health Limited

Company Information
for the Year Ended 30 April 2024







DIRECTOR: J P Bannard-Smith





REGISTERED OFFICE: Ground Floor Rear Barn
The Brookdale Centre
Knutsford
Cheshire
WA16 0SR





REGISTERED NUMBER: 14074050 (England and Wales)





ACCOUNTANTS: EBA
Ground Floor
Rear Barn
The Brookdale Centre
Knutsford
Cheshire
WA16 0SR

Visanta Health Limited (Registered number: 14074050)

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £ £ £ £
FIXED ASSETS
Intangible assets 4 48,370 48,370
Tangible assets 5 373 333
Investments 6 25,000 25,000
73,743 73,703

CURRENT ASSETS
Debtors 7 35 635
Cash at bank 28,583 5,882
28,618 6,517
CREDITORS
Amounts falling due within one year 8 27,652 50,563
NET CURRENT ASSETS/(LIABILITIES) 966 (44,046 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

74,709

29,657

PROVISIONS FOR LIABILITIES 93 83
NET ASSETS 74,616 29,574

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 74,416 29,374
74,616 29,574

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Visanta Health Limited (Registered number: 14074050)

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 3 October 2024 and were signed by:





J P Bannard-Smith - Director


Visanta Health Limited (Registered number: 14074050)

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

Visanta Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
The director does not consider there to be any impairment of goodwill during the period.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Visanta Health Limited (Registered number: 14074050)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. INTANGIBLE FIXED ASSETS
Goodwill
£
COST
At 1 May 2023
and 30 April 2024 48,370
NET BOOK VALUE
At 30 April 2024 48,370
At 30 April 2023 48,370

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1 May 2023 499
Additions 560
Disposals (499 )
At 30 April 2024 560
DEPRECIATION
At 1 May 2023 166
Charge for year 187
Eliminated on disposal (166 )
At 30 April 2024 187
NET BOOK VALUE
At 30 April 2024 373
At 30 April 2023 333

Visanta Health Limited (Registered number: 14074050)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£
COST
At 1 May 2023
and 30 April 2024 25,000
NET BOOK VALUE
At 30 April 2024 25,000
At 30 April 2023 25,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£ £
Trade debtors - 600
Other debtors 35 35
35 635

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£ £
Taxation and social security 18,710 12,809
Other creditors 8,942 37,754
27,652 50,563

9. ULTIMATE CONTROLLING PARTY

The company is controlled by the director and his spouse.